About this Journal Submit a Manuscript Table of Contents
Epilepsy Research and Treatment
Volume 2013 (2013), Article ID 670682, 8 pages
http://dx.doi.org/10.1155/2013/670682
Review Article

Epilepsy, Antiseizure Therapy, and Sleep Cycle Parameters

Department of Neurology, Barrow Neurological Institute, 500 West Thomas Road, Suite 720, Phoenix, AZ 85013, USA

Received 15 March 2013; Revised 4 July 2013; Accepted 18 July 2013

Academic Editor: Andrea Romigi

Copyright © 2013 Vladimir Shvarts and Steve Chung. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. W. Bazil, “Parasomnias, sleep disorders, and narcolepsy—sleep-time imitators of epilepsy,” in Imitators of Epilepsy, P. W. Kaplan and R. S. Fisher, Eds., pp. 217–230, Demos, New York, NY, USA, 2nd edition, 2005.
  2. A. de Weerd, S. de Haas, A. Otte et al., “Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life,” Epilepsia, vol. 45, no. 11, pp. 1397–1404, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. E. G. A. van Golde, T. Gutter, and A. W. de Weerd, “Sleep disturbances in people with epilepsy; prevalence, impact and treatment,” Sleep Medicine Reviews, vol. 15, no. 6, pp. 357–368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Romigi, F. Izzi, F. Placidi et al., “Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic study,” Epilepsy and Behavior, vol. 26, no. 2, pp. 170–174, 2013. View at Publisher · View at Google Scholar
  5. N. Foldvary, M. Perry, J. Lee, D. Dinner, and H. H. Morris, “The effects of lamotrigine on sleep in patients with epilepsy,” Epilepsia, vol. 42, no. 12, pp. 1569–1573, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Placidi, M. Diomedi, A. Scalise, M. G. Marciani, A. Romigi, and G. L. Gigli, “Effect of anticonvulsants on nocturnal sleep in epilepsy,” Neurology, vol. 54, no. 5, supplement 1, pp. S25–S32, 2000. View at Scopus
  7. L. H. M. Castro, C. W. Bazil, and T. S. Walczak, “Nocturnal seizures disrupt sleep architecture and decrease sleep efficiency,” Epilepsia, vol. 38, article 49, 1997.
  8. C. W. Bazil, L. H. M. Castro, and T. S. Walczak, “Daytime seizures increase REM latency and decrease total REM,” Epilepsia, vol. 38, article 176, 1997.
  9. N. Foldvary-Schaefer, I. D. L. Sanchez, M. Karafa, E. Mascha, D. Dinner, and H. H. Morris, “Gabapentin increases slow-wave sleep in normal adults,” Epilepsia, vol. 43, no. 12, pp. 1493–1497, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Placidi, A. Scalise, M. G. Marciani, A. Romigi, M. Diomedi, and G. L. Gigli, “Effect of antiepileptic drugs on sleep,” Clinical Neurophysiology, vol. 111, supplement 2, pp. S115–S119, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. C. W. Bazil, L. H. M. Castro, and T. S. Walczak, “Reduction of rapid eye movement sleep by diurnal and nocturnal seizures in temporal lobe epilepsy,” Archives of Neurology, vol. 57, no. 3, pp. 363–368, 2000. View at Scopus
  12. R. Manni and A. Tartara, “Evaluation of sleepiness in epilepsy,” Clinical Neurophysiology, vol. 111, supplement 2, pp. S111–S114, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. M. E. Drake Jr., S. J. Weate, S. A. Newell, H. Padamadan, and A. Pakalnis, “Multiple sleep latency tests in epilepsy,” Clinical EEG Electroencephalography, vol. 25, no. 2, pp. 59–62, 1994. View at Scopus
  14. M. C. Salinsky, B. S. Oken, and L. M. Binder, “Assessment of drowsiness in epilepsy patients receiving chronic antiepileptic drug therapy,” Epilepsia, vol. 37, no. 2, pp. 181–187, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. M. C. Salinsky, B. S. Oken, D. Storzbach, and C. B. Dodrill, “Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures,” Epilepsia, vol. 44, no. 8, pp. 1042–1050, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. E. N. Ringdahl, S. L. Pereira, and J. E. Delzell Jr., “Treatment of primary insomnia,” Journal of the American Board of Family Practice, vol. 17, no. 3, pp. 212–219, 2004. View at Scopus
  17. M. T. Smith, M. L. Perlis, A. Park et al., “Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia,” The American Journal of Psychiatry, vol. 159, no. 1, pp. 5–11, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Vendrame, B. Yang, S. Jackson, and S. H. Auerbach, “Insomnia and epilepsy: a questionnaire-based study,” Journal of Clinical Sleep Medicine, vol. 9, no. 2, pp. 141–146, 2013. View at Publisher · View at Google Scholar
  19. J. Piedad, H. Rickards, F. M. C. Besag, and A. E. Cavanna, “Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations,” CNS Drugs, vol. 26, no. 4, pp. 319–335, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Méndez and R. A. Radtke, “Interactions between sleep and epilepsy,” Journal of Clinical Neurophysiology, vol. 18, no. 2, pp. 106–127, 2001. View at Scopus
  21. B. Legros and C. W. Bazil, “Effects of antiepileptic drugs on sleep architecture: a pilot study,” Sleep Medicine, vol. 4, no. 1, pp. 51–55, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. G. L. Gigli, F. Placidi, M. Diomedi et al., “Nocturnal sleep and daytime somnolence in untreated patients with temporal lobe epilepsy: changes after treatment with controlled-release carbamazepine,” Epilepsia, vol. 38, no. 6, pp. 696–701, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. W. Cho, D. H. Kim, and G. K. Motamedi, “The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy,” Seizure, vol. 20, no. 4, pp. 336–339, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Placidi, M. G. Marciani, M. Diomedi et al., “Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy,” Acta Neurologica Scandinavica, vol. 102, no. 2, pp. 81–86, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. L. J. Hirsch, D. Weintraub, Y. Du et al., “Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy,” Neurology, vol. 63, no. 6, pp. 1022–1026, 2004. View at Scopus
  26. M. Sadler, “Lamotrigine associated with insomnia,” Epilepsia, vol. 40, no. 3, pp. 322–325, 1999. View at Scopus
  27. M. J. Brodie, R. Duncan, H. Vespignani, A. Solyom, V. Bitenskyy, and C. Lucas, “Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures,” Epilepsia, vol. 46, no. 1, pp. 31–41, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Cormier and C. J. Chu, “Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age,” Neuropsychiatric Disease and Treatment, vol. 9, pp. 295–306, 2013.
  29. S. D. Shorvon, A. Löwenthal, D. Janz, E. Bielen, and P. Loiseau, “Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures,” Epilepsia, vol. 41, no. 9, pp. 1179–1186, 2000. View at Scopus
  30. E. Ben-Menachem and U. Falter, “Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy,” Epilepsia, vol. 41, no. 10, pp. 1276–1283, 2000. View at Scopus
  31. J. J. Cereghino, V. Biton, B. Abou-Khalil, F. Dreifuss, L. J. Gauer, and I. Leppik, “Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial,” Neurology, vol. 55, no. 2, pp. 236–242, 2000. View at Scopus
  32. J. J. Tsai, D. J. Yen, M. S. Hsih et al., “Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study,” Epilepsia, vol. 47, no. 1, pp. 72–81, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Cicolin, U. Magliola, A. Giordano, A. Terreni, C. Bucca, and R. Mutani, “Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers,” Epilepsia, vol. 47, no. 1, pp. 82–85, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Bell, H. Vanderlinden, R. Hiersemenzel, C. Otoul, D. Nutt, and S. Wilson, “The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy,” Journal of Sleep Research, vol. 11, no. 3, pp. 255–263, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Helmstaedter, N. E. Fritz, E. Kockelmann, N. Kosanetzky, and C. E. Elger, “Positive and negative psychotropic effects of levetiracetam,” Epilepsy and Behavior, vol. 13, no. 3, pp. 535–541, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. T. A. Glauser, “Topiramate,” Epilepsia, vol. 40, supplement 5, pp. S71–S80, 1999. View at Scopus
  37. V. Biton, K. R. Edwards, G. D. Montouris, J. C. Sackellares, C. L. Harden, and M. Kamin, “Topiramate titration and tolerability,” Annals of Pharmacotherapy, vol. 35, no. 2, pp. 173–179, 2001. View at Scopus
  38. R. Reife, G. Pledger, and S. Wu, “Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults,” Epilepsia, vol. 41, supplement 1, pp. S66–S71, 2000. View at Scopus
  39. F. G. Gilliam, “Tolerability of topiramate as monotherapy in patients with recently diagnosed partial epilepsy,” Epilepsia, vol. 39, supplement 6, article 56, 1998.
  40. E. Bonanni, R. Galli, M. Maestri et al., “Daytime sleepiness in epilepsy patients receiving topiramate monotherapy,” Epilepsia, vol. 45, no. 4, pp. 333–337, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Placidi, D. Mattia, A. Romigi, M. A. Bassetti, F. Spanedda, and M. G. Marciani, “Gabapentin-induced modulation of interictal epileptiform activity related to different vigilance levels,” Clinical Neurophysiology, vol. 111, no. 9, pp. 1637–1642, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Beydoun, B. M. Uthman, A. R. Kugler, M. J. Greiner, L. E. Knapp, and E. A. Garofalo, “Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy,” Neurology, vol. 64, no. 3, pp. 475–480, 2005. View at Scopus
  43. J. A. French, A. R. Kugler, J. L. Robbins, L. E. Knapp, and E. A. Garofalo, “Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures,” Neurology, vol. 60, no. 10, pp. 1631–1637, 2003. View at Scopus
  44. S. Arroyo, H. Anhut, A. R. Kugler et al., “Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures,” Epilepsia, vol. 45, no. 1, pp. 20–27, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. M. J. Brodie, “Pregabalin as adjunctive therapy for partial seizures,” Epilepsia, vol. 45, supplement 6, pp. 19–27, 2004. View at Scopus
  46. I. Hindmarch, J. Dawson, and N. Stanley, “A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo,” Sleep, vol. 28, no. 2, pp. 187–193, 2005. View at Scopus
  47. S. de Haas, A. Otte, A. de Weerd, G. van Erp, A. Cohen, and J. van Gerven, “Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy,” Journal of Clinical Sleep Medicine, vol. 3, no. 5, pp. 473–478, 2007. View at Scopus
  48. A. Romigi, F. Izzi, M. G. Marciani et al., “Pregabalin as add-on therapy induces REM sleep enhancement in partial epilepsy: a polysomnographic study,” European Journal of Neurology, vol. 16, no. 1, pp. 70–75, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. J. C. Henry and R. A. Gross, “Epilepsy,” in Principles of Drug Therapy in Neurology, M. V. Johnston and R. A. Gross, Eds., pp. 75–151, Oxford University Press, New York, NY, USA, 2nd edition, 2008.
  50. H. E. Siegel, K. Hunter, F. Vega-Bermudez, et al., “The effects of vigabatrin on the REM sleep of patients with complex partial seizures,” Epilepsia, vol. 39, article 199, 1998.
  51. M. A. Rogawski, “Revisiting AMPA receptors as an antiepileptic drug target,” Epilepsy Currents, vol. 11, no. 2, pp. 56–63, 2011.
  52. J. A. French, G. L. Krauss, V. Biton et al., “Adjunctive perampanel for refractory partial-onset seizures,” Neurology, vol. 79, no. 6, pp. 589–596, 2012. View at Publisher · View at Google Scholar
  53. J. A. French, G. L. Krauss, B. J. Steinhoff et al., “Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305,” Epilepsia, vol. 54, no. 1, pp. 117–125, 2013. View at Publisher · View at Google Scholar
  54. G. L. Krauss, M. Bar, V. Biton et al., “Tolerability and safety of perampanel: two randomized dose-escalation studies,” Acta Neurologica Scandinavica, vol. 125, no. 1, pp. 8–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. G. L. Krauss, E. Perucca, E. Ben-Menachem et al., “Perampanel, a selective, noncompetitive a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307,” Epilepsia, vol. 54, no. 1, pp. 126–134, 2013. View at Publisher · View at Google Scholar
  56. G. L. Krauss, J. M. Serratosa, V. Villanueva et al., “Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures,” Neurology, vol. 78, no. 18, pp. 1408–1415, 2012. View at Publisher · View at Google Scholar
  57. I. Rektor, G. L. Krauss, M. Bar et al., “Perampanel study 207: long-term open-label evaluation in patients with epilepsy,” Acta Neurologica Scandinavica, vol. 126, no. 4, pp. 263–269, 2012. View at Publisher · View at Google Scholar
  58. S. Grosso, D. M. Cordelli, G. Coppola et al., “Efficacy and safety of felbamate in children under 4 years of age: a retrospective chart review,” European Journal of Neurology, vol. 15, no. 9, pp. 940–946, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Beydoun, J. D'Souza, D. Hebert, and P. Doty, “Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures,” Expert Review of Neurotherapeutics, vol. 9, no. 1, pp. 33–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Loddenkemper, “Chrono-epiloptology: time to reconsider seizure timing,” Seizure, vol. 21, no. 6, p. 411, 2012. View at Publisher · View at Google Scholar
  61. T. Loddenkemper, S. W. Lockley, J. Kaleyias, and S. V. Kothare, “Chronobiology of epilepsy: diagnostic and therapeutic implications of chrono-epileptology,” Journal of Clinical Neurophysiology, vol. 28, no. 2, pp. 146–153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. W. A. Hofstra, M. C. M. Gordijn, J. van der Palen, R. van Regteren, B. E. Grootemarsink, and A. W. de Weerd, “Timing of temporal and frontal seizures in relation to the circadian phase: a prospective pilot study,” Epilepsy Research, vol. 94, no. 3, pp. 158–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. T. Gholipour, M. Ghasemi, K. Riazi, M. Ghaffarpour, and A. R. Dehpour, “Seizure susceptibility alteration through 5-HT3 receptor: modulation by nitric oxide,” Seizure, vol. 19, no. 1, pp. 17–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Gupta, S. Aneja, and K. Kohli, “Add-on melatonin improves quality of life in epileptic children on valproate monotherapy: a randomized, double-blind, placebo-controlled trial,” Epilepsy and Behavior, vol. 5, no. 3, pp. 316–321, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. L. S. Stewart and L. S. Leung, “Hippocampal melatonin receptors modulate seizure threshold,” Epilepsia, vol. 46, no. 4, pp. 473–480, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Mirzoev, E. Bercovici, L. S. Stewart, M. A. Cortez, O. C. Snead III, and M. Desrocher, “Circadian profiles of focal epileptic seizures: a need for reappraisal,” Seizure, vol. 21, no. 6, pp. 412–416, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. M. K. Smyk, A. M. L. Coenen, M. H. Lewandowski, and G. van Luijtelaar, “Endogenous rhythm of absence epilepsy: relationship with general motor activity and sleep-wake states,” Epilepsy Research, vol. 93, no. 2-3, pp. 120–127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. W. A. Hofstra, J. van der Palen, and A. W. de Weerd, “Morningness and eveningness: when do patients take their antiepileptic drugs?” Epilepsy and Behavior, vol. 23, no. 3, pp. 320–323, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. L. M. F. F. Guilhoto, T. Loddenkemper, M. Vendrame, A. Bergin, B. F. Bourgeois, and S. V. Kothare, “Higher evening antiepileptic drug dose for nocturnal and early-morning seizures,” Epilepsy and Behavior, vol. 20, no. 2, pp. 334–337, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. C. W. Bazil, “Effects of antiepileptic drugs on sleep structure: are all drugs equal?” CNS Drugs, vol. 17, no. 10, pp. 719–728, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. C. W. Bazil, “Epilepsy and sleep disturbance,” Epilepsy and Behavior, vol. 4, no. 2, pp. S39–S45, 2003. View at Scopus
  72. M. Sammaritano and A. Sherwin, “Effect of anticonvulsants on sleep,” Neurology, vol. 54, no. 5, pp. S16–S24, 2000. View at Scopus
  73. M. N. Shouse, C. W. Bazil, and B. A. Malow, “Sleep,” in Epilepsy: A Comprehensive Textbook, J. Engel and T. Pedley, Eds., pp. 1976–1990, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2nd edition, 2008.